Obesity attenuates gender differences in cardiovascular mortality

Table 2 Baseline characteristics of participants by body mass index and sex

	<25.0 kg/m²			25.0-29.9 kg/m²			30.0-34.9 kg/m²			≥35.0 kg/m²
	M (n = 9275)	F (n = 10 519)	P*	M (n = 10 738)	F (n = 7142)	P*	M (n = 3017)	F (n = 2962)	P*	M (n = 599)	F (n = 1342)	P*
Age (years)	45.6 (11.8)	42.9 (11.7)	0.00	49.0 (11.5)	49.7 (11.7)	0.00	51.3 (11.3)	52.3 (11.5)	0.00	50.6 (11.3)	52.4 (11.1)	0.00
Abdominal obesity (%)^†
WC	0.6	1.3	0.00	26.9	24.2	0.00	91.4	79.3	0.00	99.7	98.1	0.01
WHR	5.3	8.6	0.00	27.4	30.1	0.00	64.3	52.6	0.00	85.1	66.0	0.00
WHtR	0.6	1.2	0.00	23.7	23.1	0.35	89.5	81.0	0.00	99.7	99.0	0.17
Diabetes status (%)^†			0.27			0.00			0.00			0.04
Newly diagnosed diabetes	11.3	10.2		13.4	16.0		19.5	24.8		24.4	32.6
Known diabetes	3.2	3.2		6.0	5.4		11.6	10.2		17.2	15.0
Smoking status (%)			0.00			0.00			0.00			0.00
Current smokers	25.6	22.1		23.7	17.6		25.3	15.1		25.2	13.5
Former smokers	27.9	17.3		34.6	18.7		38.7	18.7		38.2	18.7
Physically active (%)	83.1	78.6	0.00	80.4	77.7	0.00	73.3	70.7	0.03	61.9	62.1	0.96
SBP (mmHg)^§	127 (17)	124 (18)	0.00	135 (18)	133 (21)	0.00	142 (19)	140 (21)	0.00	147 (20)	145 (22)	0.04
FPG (mmol/L)^§	5.3 (0.9)	5.2 (0.8)	0.00	5.5 (1.1)	5.4 (1.0)	0.00	5.9 (1.5)	5.7 (1.3)	0.00	6.4 (2.2)	5.9 (1.7)	0.00
TG (mmol/L)^§	1.3 (0.9)	1.0 (0.6)	0.00	1.8 (1.2)	1.4 (0.8)	0.00	2.2 (1.5)	1.6 (1.0)	0.00	2.5 (1.9)	1.9 (1.2)	0.00
HDL-C (mmol/L)^§	1.4 (0.4)	1.7 (0.4)	0.00	1.2 (0.3)	1.5 (0.4)	0.00	1.1 (0.3)	1.4 (0.4)	0.00	1.1 (0.3)	1.3 (0.3)	0.00
Total-C (mmol/L)^§	5.7 (1.2)	5.5 (1.2)	0.00	6.0 (1.2)	5.9 (1.3)	0.00	6.0 (1.2)	5.9 (1.2)	0.04	5.9 (1.2)	5.8 (1.2)	0.61

Abbreviations: M male, F female, WC waist circumference, WHR waist-to-hip ratio, WHtR waist-to-height ratio, SBP systolic blood pressure, FPG fasting plasma glucose, TG triglyceride, HDL-C high-density lipoprotein cholesterol, Total-C total cholesterol.
Data are means (standard deviations) or as noted.
*Difference between men and women.
^†The top quartile of WC, WHR or WHtR in women (90 cm, 0.85 or 0.56) and in men (99 cm, 0.97 or 0.57) was used as abdominal obesity group.
^†21 555 individuals with information on diabetes status, including 1285 with known diagnosis of diabetes and 20 270 with available measurement of fasting plasma glucose and/or 75 g 2-h oral glucose tolerance test (44.7% women).
^§45 573 individuals with available measurement of SBP, 20 759 for FPG, 36 834 for TG, 41 808 for HDL-C and 45 353 for Total-C.

ISSN: 1475-2840